Ying-Qiang Guo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ying-Qiang Guo has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Ben-Gui Zhang
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication- Ben-Gui Zhang
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China
1 shared publication Jun Shi
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication- Jun Shi
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China
1 shared publication Wen-Jun Ren
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publicationZhi-Xuan Bai
Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
1 shared publication
Latest Publications
- Open Access
- 11 August 2016
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 23 (6) , 856-860
A modified Cox maze IV procedure: a simpler technique for the surgical treatment of atrial fibrillation
To determine the effectiveness of a simplified surgical treatment method for atrial fibrillation (AF). Between September 2012 and October 2013, 120 patients (mean age, 52.3 ± 8.8 years) underwent valve surgery and concomitant bipolar radiofrequency ablation for the treatment of AF. Patients were randomized to a Cox maze IV procedure (CMP-IV) group (n = 60) or a modified CMP-IV (MCMP-IV) group (n = 60). Freedom from AF was defined as freedom from any left atrial arrhythmia lasting P < 0.001). The mean follow-up time was 32.4 ± 3.6 months (range, 26–39 months). Freedom from AF tended to be higher, but not significantly so, among the MCMP-IV group than among the CMP-IV group over the entire follow-up period. The MCMP-IV is an effective surgical procedure for the treatment of AF. In certain patients, such as those with anatomic variations of the pulmonary veins, the MCMP-IV is simpler than the CMP-IV. ChiCTR-TRC-12002742.
- 11 August 2016
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 23 (6) , 856-860
Open AccessA modified Cox maze IV procedure: a simpler technique for the surgical treatment of atrial fibrillation
To determine the effectiveness of a simplified surgical treatment method for atrial fibrillation (AF). Between September 2012 and October 2013, 120 patients (mean age, 52.3 ± 8.8 years) underwent valve surgery and concomitant bipolar radiofrequency ablation for the treatment of AF. Patients were randomized to a Cox maze IV procedure (CMP-IV) group (n = 60) or a modified CMP-IV (MCMP-IV) group (n = 60). Freedom from AF was defined as freedom from any left atrial arrhythmia lasting P < 0.001). The mean follow-up time was 32.4 ± 3.6 months (range, 26–39 months). Freedom from AF tended to be higher, but not significantly so, among the MCMP-IV group than among the CMP-IV group over the entire follow-up period. The MCMP-IV is an effective surgical procedure for the treatment of AF. In certain patients, such as those with anatomic variations of the pulmonary veins, the MCMP-IV is simpler than the CMP-IV. ChiCTR-TRC-12002742.
- Open Access
- 16 January 2016
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 11 (1) , 1-4
Papillary fibroelastoma of the aortic valve in association with rheumatic heart disease: a case report
Papillary fibroelastoma (PFE) is a rare primary cardiac neoplasm that is usually discovered incidentally at autopsy or during cardiac surgery. PFE combined with rheumatic heart disease (RHD) is extremely rare, and only a few cases have been reported. Additionally, the growth rate of the tumor is unknown. Here, we present a very rare case of PFE of the aortic valve combined with RHD, which were identified in a female patient who survived for 5 years without surgical intervention, and who subsequently underwent successful surgical treatment. PFEs may be generally slow-growing tumors, however, the better treatment of choice may be surgery because it produces good curative effects with very low risk of complications, while preventing serious disease consequences.
- 16 January 2016
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 11 (1) , 1-4
Open AccessPapillary fibroelastoma of the aortic valve in association with rheumatic heart disease: a case report
Papillary fibroelastoma (PFE) is a rare primary cardiac neoplasm that is usually discovered incidentally at autopsy or during cardiac surgery. PFE combined with rheumatic heart disease (RHD) is extremely rare, and only a few cases have been reported. Additionally, the growth rate of the tumor is unknown. Here, we present a very rare case of PFE of the aortic valve combined with RHD, which were identified in a female patient who survived for 5 years without surgical intervention, and who subsequently underwent successful surgical treatment. PFEs may be generally slow-growing tumors, however, the better treatment of choice may be surgery because it produces good curative effects with very low risk of complications, while preventing serious disease consequences.